Skip to main content
. 2020 Apr 26;14(10):1413–1423. doi: 10.1093/ecco-jcc/jjaa087

Figure 4.

Figure 4.

Relapse rates after anti-TNFα de-escalation at 1 year and 2 years. Relapse was slightly higher when compared with cumulative rates of relapse, as patients who required treatment with anti-TNFα likely had more aggressive disease. TNF, tumour necrosis factor.